AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AMN - US0017441017 - Common Stock
16.8 USD
-0.15 (-0.88%)
16.91 USD
+0.11 (+0.65%)
We assign a fundamental rating of 4 out of 10 to AMN. AMN was compared to 101 industry peers in the Health Care Providers & Services industry. AMN has an average financial health and profitability rating. AMN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AMN was profitable.
AMN had a positive operating cash flow in the past year.
Of the past 5 years AMN 4 years were profitable.
AMN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
AMN has a worse Return On Assets (-12.88%) than 76.24% of its industry peers.
With a Return On Equity value of -42.76%, AMN is not doing good in the industry: 72.28% of the companies in the same industry are doing better.
The Return On Invested Capital of AMN (2.08%) is comparable to the rest of the industry.
AMN had an Average Return On Invested Capital over the past 3 years of 13.14%. This is above the industry average of 9.22%.
The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(2.08%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROIC | 2.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN's Operating Margin of 1.65% is in line compared to the rest of the industry. AMN outperforms 46.53% of its industry peers.
AMN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 29.37%, AMN is in line with its industry, outperforming 56.44% of the companies in the same industry.
AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMN is creating some value.
AMN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AMN has been reduced compared to 5 years ago.
AMN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.41 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
AMN has a Altman-Z score of 2.41. This is comparable to the rest of the industry: AMN outperforms 54.46% of its industry peers.
AMN has a debt to FCF ratio of 3.80. This is a good value and a sign of high solvency as AMN would need 3.80 years to pay back of all of its debts.
AMN's Debt to FCF ratio of 3.80 is fine compared to the rest of the industry. AMN outperforms 73.27% of its industry peers.
AMN has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.31, AMN is doing worse than 65.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 2.41 |
ROIC/WACC0.27
WACC7.78%
2.3 Liquidity
A Current Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
AMN has a worse Current ratio (1.05) than 67.33% of its industry peers.
AMN has a Quick Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AMN (1.05) is worse than 61.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -51.29% in the last year.
Measured over the past 5 years, AMN shows a small growth in Earnings Per Share. The EPS has been growing by 0.80% on average per year.
The Revenue for AMN has decreased by -11.42% in the past year. This is quite bad
Measured over the past years, AMN shows a small growth in Revenue. The Revenue has been growing by 6.07% on average per year.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
3.2 Future
AMN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.82% yearly.
AMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.40% yearly.
EPS Next Y-65.25%
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
EPS Next 5Y22.82%
Revenue Next Year-12.11%
Revenue Next 2Y-7.22%
Revenue Next 3Y-3.38%
Revenue Next 5Y4.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 8.89, which indicates a very decent valuation of AMN.
94.06% of the companies in the same industry are more expensive than AMN, based on the Price/Earnings ratio.
AMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.15.
With a Price/Forward Earnings ratio of 16.10, AMN is valued correctly.
Based on the Price/Forward Earnings ratio, AMN is valued a bit cheaper than the industry average as 76.24% of the companies are valued more expensively.
AMN is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.22, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.89 | ||
| Fwd PE | 16.1 |
4.2 Price Multiples
84.16% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 99.01% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.9 | ||
| EV/EBITDA | 7.02 |
4.3 Compensation for Growth
AMN's earnings are expected to decrease with -22.51% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)11.05
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
5. Dividend
5.1 Amount
No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
16.8
-0.15 (-0.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners105.31%
Inst Owner Change0.2%
Ins Owners0.42%
Ins Owner Change0.71%
Market Cap645.29M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target21.35 (27.08%)
Short Float %6.73%
Short Ratio2.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)4.64%
PT rev (3m)3.17%
EPS NQ rev (1m)46.18%
EPS NQ rev (3m)30.55%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.24%
Revenue NQ rev (1m)16.48%
Revenue NQ rev (3m)14.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.89 | ||
| Fwd PE | 16.1 | ||
| P/S | 0.24 | ||
| P/FCF | 2.9 | ||
| P/OCF | 2.42 | ||
| P/B | 1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.02 |
EPS(TTM)1.89
EY11.25%
EPS(NY)1.04
Fwd EY6.21%
FCF(TTM)5.8
FCFY34.53%
OCF(TTM)6.94
OCFY41.33%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)11.05
Graham Number26.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROCE | 2.81% | ||
| ROIC | 2.08% | ||
| ROICexc | 2.16% | ||
| ROICexgc | 6.84% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% | ||
| FCFM | 8.2% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 4.12 | ||
| Cap/Depr | 27.3% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 0.95 | ||
| Cash Conversion | 129.62% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.41 |
F-Score4
WACC7.78%
ROIC/WACC0.27
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-65.25%
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-12.11%
Revenue Next 2Y-7.22%
Revenue Next 3Y-3.38%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year92.53%
EBIT Next 3Y25.77%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 4 / 10 to AMN.
What is the valuation status of AMN HEALTHCARE SERVICES INC (AMN) stock?
ChartMill assigns a valuation rating of 6 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.
How financially healthy is AMN HEALTHCARE SERVICES INC?
The financial health rating of AMN HEALTHCARE SERVICES INC (AMN) is 4 / 10.